China · Delayed Price · Currency is CNY Qingdao Baheal Medical INC. Company Description
Qingdao Baheal Medical INC. engages in the research and development, production, wholesale, and retail of pharmaceutical products in China, the United States, Hong Kong, and the United Kingdom.
The company offers bone health drugs under the D-Cal brand name; digestive drugs under the Mite brand name; liver disease drugs under the Fuzhenghuayu brand name; and urological drugs under the Betanli, Harle, and Wei Xi Kang brand names.
It also provides ophthalmic drugs under the HYCOSAN brand name; tumor and other severe drugs under the Human Albumin and Xospata brand names; anti-aging and cosmeceuticals under the Quanis, Excellula, TRANSINO, and Qingchunbao brand names; diabetes drugs under the Naida, Feburic, and Naite brand names; respiratory and anti-infective products under the Klacid brand name; and medical nutrition under the Nutrasumma brand name.
The company was incorporated in 2005 and is based in Qingdao, China. Qingdao Baheal Medical INC.
is a subsidiary of BAHEAL Pharmaceutical Holdings Limited.
| Country | China |
| Founded | 2005 |
| Industry | Medical Distribution |
| Sector | Healthcare |
| Employees | 3,064 |
| CEO | Gang Fu |
Contact Details
Address: No. 88, Kaifeng Road Qingdao, 266042 China | |
| Phone | 86 53 26675 6688 |
| Website | baheal.cn |
Stock Details
| Ticker Symbol | 301015 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100004LR8 |
| SIC Code | 5122 |
Key Executives
| Name | Position |
|---|---|
| Gang Fu | Chairman and GM |
| Yuan Zhang | Deputy General Manager |
| Zhen Li | Financial Director, Secretary, Director and Deputy GM |
| Feng Liu | Accounting Supervisor |
| Xiaowei Zhu | Deputy GM and Director |
| Ting Wei Wang | Deputy General Manager |
| Bi Quan Wang | Deputy General Manager |